【火热】大涨1409%的潜力产品,新华制药拿下国产第二家

米内网
05 Jun

精彩内容6月4日,国家药监局发布最新药品获批信息,山东新华制药的二十碳五烯酸乙酯软胶囊和注射用硫酸艾沙康唑同日获批。二十碳五烯酸乙酯软胶囊为国产第二家获批,注射用硫酸艾沙康唑2024年在中国三大终端六大市场的销售额接近2亿元。今年以来,山东新华制药已累计有7个新品获批。图1:山东新华制药最新获批的产品来源:国家药监局官网二十碳五烯酸乙酯软胶囊是一款血脂调节剂,米内网数据显示,2023年2月四川国为...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10